Meyer, A., Horton, D., Neugebauer, N., Wooters, T., , Dwoskin, L., & Bardo, M. (2011). Tetrabenazine inhibition of monoamine uptake and methamphetamine behavioral effects: locomotor activity, drug discrimination and self-administration. Neuropharmacology, 61(4), 849-56. https://doi.org/10.1016/j.neuropharm.2011.05.033

Horton, D., Siripurapu, K., Norrholm, S., Culver, J., Hojahmat, M., Beckmann, J., … Dwoskin, L. (2011). meso-Transdiene analogs inhibit vesicular monoamine transporter-2 function and methamphetamine-evoked dopamine release. The Journal of Pharmacology and Experimental Therapeutics, 336(3), 940-51. https://doi.org/10.1124/jpet.110.175117

Beckmann, J., Siripurapu, K., , Horton, D., Denehy, E., Vartak, A., … Bardo, M. (2010). The novel pyrrolidine nor-lobelane analog UKCP-110 cis-2,5-di-(2-phenethyl)-pyrrolidine hydrochloride inhibits VMAT2 function, methamphetamine-evoked dopamine release, and methamphetamine self-administration in rats. The Journal of Pharmacology and Experimental Therapeutics, 335(3), 841-51. https://doi.org/10.1124/jpet.110.172742

Beckmann, J., Meyer, A., Pivavarchyk, M., Horton, D., Zheng, G., Smith, A., … Dwoskin, L. (2015). r-bPiDI, an α6β2* Nicotinic Receptor Antagonist, Decreases Nicotine-Evoked Dopamine Release and Nicotine Reinforcement. Neurochemical Research, 40(10), 2121-30. https://doi.org/10.1007/s11064-015-1680-4